Blasco-Turrión, S, Crespo-Leiro, MG, Trenado, VD, Hion, PL, Molina, BD, Roura, G, Alvarez-Osorio, MP, Gómez-bueno, M, Bautista, CO, Diaz, JF, Bravo, IPG, Moreno, R, Sarnago-Cebada, F, González, NS, Hernandez, JM, del Blanco, BG, Farrero, M, Nadal, RO, Martin, P, de la Fuente, L, Sanz-Sánchez, J, Pérez, SM, Fernández, VA, Hospital, JAG, Granados, AL, Couto-Mallon, D, Espinosa, M, Sousa, DR, Zatarain-Nicolás, E, Aizpurua, DA, Vilella, RL, Roman, JAS, Amat-Santos, IJ. Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2024; 413DOI:10.1016/j.ijcard.2024.132340. PMID:38992809. IF:3.200(Q2/3D).

Freixa, X, Cruz-Gonzalez, I, Cepas-Guillen, P, Millan, X, Antunez-Muinos, P, Flores-Umanzor, E, Asmarats, L, Regueiro, A, Lopez-Tejero, S, Li, CHP, Sanchis, L, Rodes-Cabau, J, Arzamendi, D. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial. JAMA Cardiology. 2024; 9(10)DOI:10.1001/jamacardio.2024.2335. PMID:39110427. IF:14.100(Q1/1D).

Marcos, MC, de la Espriella, R, Comín-Colet, J, Zegrí-Reiriz, I, Gracia, JR, Morales-Rull, JL, Llàcer, P, Díez-Villanueva, P, Jiménez-Marrero, S, Bagudá, JD, Cortés, CO, Restrepo-Córdoba, MA, Goirigolzarri-Artaza, J, García-Pinilla, JM, Barrios, E, Díaz, SD, Hernández, EM, Sanchez-Marteles, M, Núñez, J. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26(10)DOI:10.1002/ejhf.3390. PMID:39056478. IF:10.800(Q1/1D).

Provencio, M, Campos, B, Guirado, M, Vilà, L, Campelo, MRG, Dorta, M, Estévez, SV, Ferrandez, A, Sala, MA, Ortega, AL, Blasco, A, Insa, A, Areses, MC, Sullivan, I, Castro, RL, Calvo, V, Rodríguez -Abreu, D, Bosch-Barrera, J, López-Martín, A, Marsé, R, Torrado, L, Matskov, K, Giner, J, Bruno, MF, Saugar, ES, Martínez-Toledo, C, Cruz-Bermudez, A. APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).